Stock SPRY ARS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions ARS Pharmaceuticals, Inc.

Equities

SPRY

US82835W1080

Real-time Estimate Cboe BZX
Other stock markets
 01:30:46 2024-06-10 pm EDT 		5-day change 1st Jan Change
9.01 USD +2.27% Intraday chart for ARS Pharmaceuticals, Inc. -0.44% +64.23%
May. 09 ARS Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 30 ARS Pharmaceuticals, Inc. Submits Response for Neffy (Epinephrine Nasal Spray) Marketing Authorization Application to EMA's Chmp CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. SPRY Stock
  4. Revisions ARS Pharmaceuticals, Inc.